Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 473

1.

The oncogene metadherin modulates the apoptotic pathway based on the tumor necrosis factor superfamily member TRAIL (Tumor Necrosis Factor-related Apoptosis-inducing Ligand) in breast cancer.

Zhang N, Wang X, Huo Q, Li X, Wang H, Schneider P, Hu G, Yang Q.

J Biol Chem. 2013 Mar 29;288(13):9396-407. doi: 10.1074/jbc.M112.395913. Epub 2013 Feb 13.

2.
3.

Seleno-cyclodextrin sensitises human breast cancer cells to TRAIL-induced apoptosis through DR5 induction and NF-κB suppression.

Lin T, Ding Z, Li N, Xu J, Luo G, Liu J, Shen J.

Eur J Cancer. 2011 Aug;47(12):1890-907. doi: 10.1016/j.ejca.2011.04.004. Epub 2011 May 10.

PMID:
21565489
4.
5.
11.

Modulation of tumor necrosis factor apoptosis-inducing ligand- induced NF-kappa B activation by inhibition of apical caspases.

Harper N, Farrow SN, Kaptein A, Cohen GM, MacFarlane M.

J Biol Chem. 2001 Sep 14;276(37):34743-52. Epub 2001 Jul 18.

13.

Tumor necrosis factor-related apoptosis-inducing ligand cooperates with anticancer drugs to overcome chemoresistance in antiapoptotic Bcl-2 family members expressing jurkat cells.

Ballestrero A, Nencioni A, Boy D, Rocco I, Garuti A, Mela GS, Van Parijs L, Brossart P, Wesselborg S, Patrone F.

Clin Cancer Res. 2004 Feb 15;10(4):1463-70.

15.

Knockdown of MTDH sensitizes endometrial cancer cells to cell death induction by death receptor ligand TRAIL and HDAC inhibitor LBH589 co-treatment.

Meng X, Brachova P, Yang S, Xiong Z, Zhang Y, Thiel KW, Leslie KK.

PLoS One. 2011;6(6):e20920. doi: 10.1371/journal.pone.0020920. Epub 2011 Jun 8.

17.

Imatinib enhances human melanoma cell susceptibility to TRAIL-induced cell death: Relationship to Bcl-2 family and caspase activation.

Hamaï A, Richon C, Meslin F, Faure F, Kauffmann A, Lecluse Y, Jalil A, Larue L, Avril MF, Chouaib S, Mehrpour M.

Oncogene. 2006 Dec 7;25(58):7618-34. Epub 2006 Sep 18. Erratum in: Oncogene. 2007 Feb 22;26(8):1256.

PMID:
16983347
18.
19.

Subtoxic concentration of doxorubicin enhances TRAIL-induced apoptosis in human prostate cancer cell line LNCaP.

Kang J, Bu J, Hao Y, Chen F.

Prostate Cancer Prostatic Dis. 2005;8(3):274-9.

PMID:
15897917
20.

Pretreatment with AT-101 enhances tumor necrosis factor-related apoptosis-inducing ligand (TRAIL)-induced apoptosis of breast cancer cells by inducing death receptors 4 and 5 protein levels.

Kisim A, Atmaca H, Cakar B, Karabulut B, Sezgin C, Uzunoglu S, Uslu R, Karaca B.

J Cancer Res Clin Oncol. 2012 Jul;138(7):1155-63. doi: 10.1007/s00432-012-1187-1. Epub 2012 Mar 13.

PMID:
22411600

Supplemental Content

Support Center